NTNutte Tarn Teraphongphom

Nutte Tarn Teraphongphom

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nutte Tarn Teraphongphom has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Combining Optical Coherence Tomography and Fractional Flow Reserve for Decision Making in Percutaneous Coronary Intervention: Insights From the FUSION Study

    by Rick H.J.A. Volleberg, Doosup Shin, Richard A. Shlofmitz, Aziz Maksoud, Bassem Chehab, Kanitha Phalakornkule, Jana Buccola, Nutte Tarn Teraphongphom, Ajay Gopinath, Ashley Netravali, et al.

  • Open Access

    Optical Coherence Tomography–Based Functional Stenosis Assessment: FUSION—A Prospective Multicenter Trial

    by Allen Jeremias, Akiko Maehara, Mitsuaki Matsumura, Richard A. Shlofmitz, Aziz Maksoud, Takashi Akasaka, Hiram G. Bezerra, William F. Fearon, Habib Samady, Bruce Samuels, et al.

    BACKGROUND: Intravascular imaging and intracoronary physiology may both be used to guide and optimize percutaneous coronary intervention; however, they are rarely used together. The virtual flow reserve (VFR) is an optical coherence tomography (OCT)–based model of fractional flow reserve (FFR) facilitating the assessment of the physiological significance of coronary lesions. We aimed to validate the VFR assessment of intermediate coronary artery stenoses. METHODS: FUSION (Validation of OCT-Based Functional Diagnosis of Coronary Stenosis) was a multicenter, prospective, observational study comparing OCT-derived VFR to invasive FFR. VFR was mathematically derived from a lumped parameter flow model based on 3-dimensional lumen morphology. Patients undergoing coronary angiography with intermediate angiographic stenosis (40%–90%) requiring physiological assessment were enrolled. Investigational sites were blinded to the VFR analysis, and all OCT and FFR data were reviewed by an independent core laboratory. The coprimary end points were the sensitivity and specificity of VFR against FFR as the reference standard, each of which was tested against prespecified performance goals. RESULTS: After core laboratory review, 266 vessels in 224 patients from 25 US centers were included in the analysis. The mean angiographic diameter stenosis was 65.5%±14.9%, and the mean FFR was 0.83±0.11. Overall accuracy, sensitivity, and specificity of VFR versus FFR using a binary cutoff point of 0.80 were 82.0%, 80.4%, and 82.9%, respectively. The 97.5% lower confidence bound met the prespecified performance goal for sensitivity (71.6% versus 70%; P =0.01) and specificity (76.6% versus 75%; P =0.01). The area under the curve was 0.88 (95% CI, 0.84–0.92; P <0.0001). CONCLUSIONS: OCT-derived VFR demonstrates high sensitivity and specificity for predicting invasive FFR. Integrating high-resolution intravascular imaging with imaging-derived physiology may provide synergistic benefits as an adjunct to percutaneous coronary intervention. REGISTRATION: URL: https://clinicaltrials.gov ; Unique identifier: NCT04356027.


  • Open Access

    Evaluation of an Infrapopliteal Drug-Eluting Resorbable Scaffold: Design Methodology for the LIFE-BTK Randomized Controlled Trial

    by Ramon L. Varcoe, Sahil A. Parikh, Brian G. DeRubertis, Jennifer M. Jones-McMeans, Nutte Tarn Teraphongphom, Jin Wang, Raghu Kolluri, Ido Weinberg, Andrew H. Holden, Hector M. Garcia-Garcia, et al.


  • A global registry of fractional flow reserve (FFR)–guided management during routine care: Study design, baseline characteristics and outcomes of invasive management

    by Erick Schampaert, Gautam Kumar, Stephan Achenbach, Stefano Galli, Nobuhiro Tanaka, Tarn Teraphongphom, Greg Ginn, Zhen Zhang, Samer Somi, Giovanni Amoroso, et al.

    Background: The use and clinical outcomes of fractional flow reserve (FFR)–guided revascularization in patients presenting with either stable coronary artery disease (CAD) or an acute coronary syndrome (ACS) in daily clinical practice are uncertain.Objective: To prospectively characterize the frequency of the change in treatment plan when FFR is performed compared to the initial decision based on angiography alone and procedure‐related outcomes.Methods: We undertook a prospective, multicenter, multinational, open‐label, observational study of coronary physiologic measurements during clinically indicated coronary angiography. The treatment plan, including medical therapy, PCI or CABG, was prospectively recorded before and after performing FFR. Adverse events were pre‐defined and prospectively recorded per local investigators (PRESSUREwire; ClinicalTrials.gov identifier: NCT02935088).Results: Two thousand two hundred and seventeen subjects were enrolled in 70 hospitals across 15 countries between October 2016–February 2018. The mean FFR (all measurements) was 0.84. The treatment plan based on angiography‐alone changed in 763/2196 subjects (34.7%) and 872/2931 lesions (29.8%) post‐FFR. In the per‐patient analysis, the initial treatment plan based on angiography versus the final treatment plan post‐FFR were medical management 1,350 (61.5%) versus 1,470 (66.9%) (p = .0017); PCI 717 (32.7%) versus 604 (27.5%) (p = .0004); CABG 119 (5.4%) versus 121 (5.5%) (p = .8951). The frequency of intended revascularization changed from 38.1 to 33.0% per patient (p = .0005) and from 35.5 to 29.6% per lesion (p < .0001) following FFR.Conclusions: On an individual patient basis, use of FFR in everyday practice changes the treatment plan compared to angiography in more than one third of all‐comers selected for physiology‐guided managements. FFR measurement is safe, providing incremental information to guide revascularization decisions.


  • Top Cited Papers
    Open Access

    Albumin-chaperoned cyanine dye yields superbright NIR-II fluorophore with enhanced pharmacokinetics

    by Rui Tian, Qiao Zeng, Shoujun Zhu, Joseph Lau, Swati Chandra, Robert Ertsey, Kenneth S. Hettie, Tarn Teraphongphom, Zhubin Hu, Gang Niu, et al.

    Complexation of cyanine dye with albumin produces efficient NIR-II fluorophore improving the resolution of in vivo bioimaging.


  • Open Access

    Specimen mapping in head and neck cancer using fluorescence imaging

    by Nutte Teraphongphom, Christina S. Kong, Jason M. Warram, Eben L. Rosenthal

    Overview: Although the agreed‐upon standard is circumferential pathology analysis of the interface between the resected specimen and the patient, there is currently no consensus on the optimal methodology to achieve this in head and neck cancer specimens. This is most commonly conducted by either sampling the wound bed after resection or obtaining samples from the specimen. Regardless of the technique, only a fraction of the area of interest can be sampled due to the labor‐intensive nature of frozen sections.Objective: This review will cover and define the possible role for optical mapping of the surgical specimen using fluorescence imaging in head and neck cancer.Level of Evidence: NA